- Endoparasticides
- Ectoparasiticides
- Endectocides
Asia Pacific Animal Parasiticides Market size was valued at USD x billion in 2022. It is expected to reach USD x billion by 2028, at a CAGR of x% from 2023-2029. Asia Pacific Animal Parasiticides are products, which are used to kill various kinds of parasites that infect companion animals, livestock, and other animals. It contains one or more active ingredients depending upon the specific efficacy against the parasites. Animal parasiticides can be used directly or as a feed additive in livestock feed.
Drivers of Asia Pacific Animal Parasiticides Market: High prevalence of zoonotic diseases Rapid new product developments Growing concerns regarding health of animals Rise in initiatives taken by governments in prevention of infections and diseases in animals. Increase in pet adaptation Presence of large pool of livestock population Restraints of Asia Pacific Animal Parasiticides Market: High costs of products Stringent regulatory framework for product approvals Lack of Awareness regarding use of animal parasiticides
2023 is the base year and 2029 is the forecast year.
The report covers asia-pacific animal parasiticides market data: China, India, Japan, Australia & New Zealand
The asia pacific animal parasiticides market Ceva Sante Animale (France), Sanofi (France), Virbac (France), Eli Lilly and Company (U.S.), Vetoquinol S.A. (France), Merck and Co., Inc. (U.S.)